By Helga Rübsamen-Schaeff, Helmut Buschmann, Raimund Mannhold, Jörg Holenz
Discusses how to fight Ebola, SARS Corona, and other known or emerging human viruses by building on the successes in antiviral therapy of the past decades
Written by leading medicinal chemists from academia and industry, this book discusses the entire field of antiviral drug discovery and development from a medicinal chemistry perspective, focusing on antiviral drugs, targets, and viral disease mechanisms. It provides an outlook on emerging pathogens such as Ebola, Zika, West Nile, Lassa, and includes a chapter on SARS Coronoavirus-2 causing the present pandemic.
New Drug Development for Known and Emerging Viruses describes the discovery and development process for antiviral agents for different classes of viruses and targets based on the experiences from the nine human viruses for which approved drugs are on the market (HIV, HCV, Influenza, RSV, HBV, HPV, HCMV, HSV, and VZV). It covers the properties and potential of 20 classes of currently approved antivirals, including combination drugs, and looks at novel antiviral strategies against emerging viruses.
Covers the entire field of antiviral drug discovery and development
Addresses the need for antiviral drugs to combat major health threats such as Ebola, Zika, West Nile, and SARS Coronavirus-2
Summarizes the successes of the past 15 years in developing ground-breaking medicines against 9 major human viruses, both from the medicinal chemistry and the pharmacological angle
Discusses practical and strategic challenges in the drug discovery and development process, including screening technologies, latency, and toxicity issues
New Developments in Antiviral Drugs is an important book for medicinal chemists, pharmaceutical chemists, virologists, and epidemiologists, and will be of great interest to those in the ;pharmaceutical industry and public health agencies.
Read less
Product Details
Publisher : Wiley-VCH; 1st edition (January 31, 2022)
Language : English
Digital eBook : 528 pages
ISBN-10 : 3527343377
ISBN-13 : 978-3527343379

Partial Knee Arthroplasty 1st ed. 2019 Edition
New Concepts in ECG Interpretation 1st ed. 2019 Edition
A Comprehensive Guide to Nanoparticles in Medicine (PDF)
Seldin and Giebisch's The Kidney, Fifth Edition: Physiology & Pathophysiology
Lippincott's Concise Illustrated Anatomy: Volume 2: Thorax, Abdomen & Pelvis
The Johns Hopkins Internal Medicine Board Review: Certification and Recertification, 5th Edition (PDF)
Lippincott's Concise Illustrated Anatomy: Volume 3: Head & Neck
Absolute Obstetric Anesthesia Review: The Complete Study Guide for Certification and Recertification
Field Guide to Wilderness Medicine 4th
Dilemma's bij dementie
Diagnosis of Endometrial Biopsies and Curettings: A Practical Approach
Dynamic Ophthalmic Ultrasonography: A Video Atlas for Ophthalmologists and Imaging Technicians (PDF)
Adolescents with Chronic Kidney Disease
Non-Obstetric Surgery During Pregnancy: A Comprehensive Guide 1st ed. 2019 Edition, Kindle Edition
The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging 2nd
Concise Guide to Hematology 2nd ed. 2019 Edition
Mechanical Ventilation in Emergency Medicine
Chronic Headache: A Comprehensive Guide to Evaluation and Management 1st ed. 2019 Edition, Kindle Edition
101+ Careers in Public Health, 2nd Edition
Medicines, Ethics and Practice: The Professional Guide for Pharmacists
Airway Stenting in Interventional Radiology 1st ed. 2019 Edition
Telemedicine and Electronic Medicine
Translational Ayurveda
Human Brain Stem Vessels: Including the Pineal Gland and Information on Brain Stem Infarction 2nd ed. 1999 Edition
Supporting Sucking Skills In Breastfeeding Infants 2nd
Teaching Cultural Competence in Nursing and Health Care, Third Edition: Inquiry, Action, and Innovation
Epidemiology of Thyroid Disorders (EPUB)
Sexually Transmitted Infections: Diagnosis, Management, and Treatment
Anatomy of Neuropsychiatry: The New Anatomy of the Basal Forebrain and Its Implications for Neuropsychiatric Illness 1st Edition 


Reviews
There are no reviews yet.